Mirvetuximab-MMAE (ADC)

Mirvetuximab-MMAE is an ADC consisting of an FRA-directed antibody and Monomethyl auristatin E (MMAE) used for the study of ovarian cancer.

Product Specifications

Reactivity

Human

Applications

Research Grade Biosimilar

Stability

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

Endotoxin

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Form

Liquid

Notes

For research use only. Not suitable for clinical or therapeutic use.

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA503481S 30 µL

Proteasome subunit beta type 4 (PSMB4) Mouse Monoclonal Antibody [Clone ID: OTI7B4]

Ask

View Details

NBP3-08348IR 100 µL

Mouse Monoclonal Alpha Fodrin Antibody (SPTAN1/3352) [DyLight 755]

Ask

View Details

GTR15119272 1 Vial

Lentiviral human TM6SF2 shRNA (UAS) - Lentiviral human TM6SF2 shRNA (UAS, iRFP) plasmid

Ask

View Details

MBS9442771-01 0.1 mL (Biotin)

L1CAM Polyclonal Conjugated Antibody

Ask

View Details

MBS9442771-02 0.1 mL (AF350)

L1CAM Polyclonal Conjugated Antibody

Ask

View Details

MBS9442771-03 0.1 mL (AF405)

L1CAM Polyclonal Conjugated Antibody

Ask

View Details